Market
Labcorp outlays up to $872m to acquire BioReference’s laboratory assets
Labcorp agreed to acquire BioReference's laboratory assets for up to $872 million. The transaction is intended to expand Labcorp's laboratory service capacity and accessibility. BioReference operates a network of clinical laboratory facilities serving patients and providers across multiple regions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network